Literature DB >> 26909664

Consensus definition of fetal growth restriction: a Delphi procedure.

S J Gordijn1, I M Beune1, B Thilaganathan2, A Papageorghiou2, A A Baschat3, P N Baker4, R M Silver5, K Wynia6, W Ganzevoort7.   

Abstract

OBJECTIVE: To determine, by expert consensus, a definition for early and late fetal growth restriction (FGR) through a Delphi procedure.
METHOD: A Delphi survey was conducted among an international panel of experts on FGR. Panel members were provided with 18 literature-based parameters for defining FGR and were asked to rate the importance of these parameters for the diagnosis of both early and late FGR on a 5-point Likert scale. Parameters were described as solitary parameters (parameters that are sufficient to diagnose FGR, even if all other parameters are normal) and contributory parameters (parameters that require other abnormal parameter(s) to be present for the diagnosis of FGR). Consensus was sought to determine the cut-off values for accepted parameters.
RESULTS: A total of 106 experts were approached, of whom 56 agreed to participate and entered the first round, and 45 (80%) completed all four rounds. For early FGR (< 32 weeks), three solitary parameters (abdominal circumference (AC) < 3(rd) centile, estimated fetal weight (EFW) < 3(rd) centile and absent end-diastolic flow in the umbilical artery (UA)) and four contributory parameters (AC or EFW < 10(th) centile combined with a pulsatility index (PI) > 95(th) centile in either the UA or uterine artery) were agreed upon. For late FGR (≥ 32 weeks), two solitary parameters (AC or EFW < 3(rd) centile) and four contributory parameters (EFW or AC < 10(th) centile, AC or EFW crossing centiles by > two quartiles on growth charts and cerebroplacental ratio < 5(th) centile or UA-PI > 95(th) centile) were defined.
CONCLUSION: Consensus-based definitions for early and late FGR, as well as cut-off values for parameters involved, were agreed upon by a panel of experts.
Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

Keywords:  Delphi; consensus; definition; fetal growth restriction; placenta; placenta-based FGR

Mesh:

Year:  2016        PMID: 26909664     DOI: 10.1002/uog.15884

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  169 in total

1.  Femur-sparing pattern of abnormal fetal growth in pregnant women from New York City after maternal Zika virus infection.

Authors:  Christie L Walker; Audrey A Merriam; Eric O Ohuma; Manjiri K Dighe; Michael Gale; Lakshmi Rajagopal; Aris T Papageorghiou; Cynthia Gyamfi-Bannerman; Kristina M Adams Waldorf
Journal:  Am J Obstet Gynecol       Date:  2018-05-05       Impact factor: 8.661

Review 2.  Tracking placental development in health and disease.

Authors:  John D Aplin; Jenny E Myers; Kate Timms; Melissa Westwood
Journal:  Nat Rev Endocrinol       Date:  2020-06-29       Impact factor: 43.330

3.  Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Authors:  Gordon Cs Smith; Alexandros A Moraitis; David Wastlund; Jim G Thornton; Aris Papageorghiou; Julia Sanders; Alexander Ep Heazell; Stephen C Robson; Ulla Sovio; Peter Brocklehurst; Edward Cf Wilson
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

Review 4.  Fetal Growth Restriction.

Authors:  Deepti Shrivastava; Ayesha Master
Journal:  J Obstet Gynaecol India       Date:  2019-09-27

5.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

6.  Cell-Free DNA (cfDNA) Fetal Fraction in Early- and Late-Onset Fetal Growth Restriction.

Authors:  Danila Morano; Stefania Rossi; Cristina Lapucci; Maria Carla Pittalis; Antonio Farina
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

7.  Prenatal Sildenafil Therapy Improves Cardiovascular Function in Fetal Growth Restricted Offspring of Dahl Salt-Sensitive Rats.

Authors:  Fieke Terstappen; Frank T Spradley; Bhavisha A Bakrania; Sinéad M Clarke; Jaap A Joles; Nina D Paauw; Michael R Garrett; A Titia Lely; Jennifer M Sasser
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

8.  Comparison of Efficiency and Function of Vascular Endothelial Growth Factor Adenovirus Vectors in Endothelial Cells for Gene Therapy of Placental Insufficiency.

Authors:  Carlo Rossi; Mark Lees; Vedanta Mehta; Tommi Heikura; John Martin; Ian Zachary; Rebecca Spencer; Donald M Peebles; Robert Shaw; Minna Karhinen; Seppo Yla-Herttuala; Anna L David
Journal:  Hum Gene Ther       Date:  2020-11       Impact factor: 5.695

9.  Melatonin 1A and 1B Receptors' Expression Decreases in the Placenta of Women with Fetal Growth Restriction.

Authors:  Andrii M Berbets; Igor S Davydenko; Adrian M Barbe; Dmytro H Konkov; Olena M Albota; Oleksandr M Yuzko
Journal:  Reprod Sci       Date:  2020-08-17       Impact factor: 3.060

10.  Potential pathophysiological role of microRNA 193b-5p in human placentae from pregnancies complicated by preeclampsia and intrauterine growth restriction.

Authors:  Zain Awamleh; Victor K M Han
Journal:  Mol Biol Rep       Date:  2020-08-16       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.